肝癌合并肝硬化脾亢行肿瘤联合脾切除28例临床分析  

Clinical analysis of 28 patients on hepatectomy combined with splenctomy for primary liver cancer associated with liver cirrhosis and hypersplenism

作　　者：李湘竑[1] 汪谦[1] 孙凯[1] 梁力健[1] 黄洁夫[1] 

机构地区：[1]中山大学附属第一医院肝胆外科,广州市510080

出　　处：《岭南现代临床外科》2005年第1期3-4,9,共3页Lingnan Modern Clinics in Surgery

摘　　要：目的探讨肝癌合并肝硬化脾功能亢进患者行原发性肝癌切除联合脾切除的临床疗效。方法对1996.1～2002.12间经我院手术治疗的28例肝癌合并肝硬化脾功能亢进患者的临床资料进行回顾性分析。结果28例患者行原发性肝脏癌肿一期切除联合脾切除,手术基本顺利,无手术死亡;术后脾亢症状基本消失,无严重手术并发症。结论对肝癌合并肝硬化脾功能亢进患者行原发性肝癌切除联合脾切除是安全有效的;加强围手术期处理是提高近期疗效的关键,且病理巨脾的切除对术后远期疗效亦是有益的。Objective To investigate the clinical effect of hepatectomy combined with and splenectomy in patients with primary liver canceer(PLC)associated with liver cirrhosis and hypersplenism.Methods From 1996.1 to 2002.12,the clinical data of 28 patients with PLC associated with liver cirrhosis and hypersplenism were analysed retrospecively.Results 28 patients underwent hepatectomy combined with splenectomy and postoperative course was unevenful.The symptoms of hypersplenism were disappeared and no serious complications were occurred after operation. Conclusion It is safe and effective to perform hepatectomy combined with splenectomy in patients with PLC associated with liver cirrhosis and hypersplenism.A careful perioperative management is very important and the pathologic splenomegaly resection is beneficial for short and long-term curative effect.

关 键 词：脾切除 肝硬化 联合 患者 脾亢 肿瘤 脾功能亢进 原发性肝癌 术后 癌肿 

分 类 号：R657[医药卫生—外科学] R735[医药卫生—临床医学]